companydata.dkcompanydata.dk

JJ PHARMA CONSULT ApS: Financial statements 2021

CVR: 33257635

Source: annual report 2021, Danish Business Authority

01/01/2021 – 31/12/2021

JJ PHARMA CONSULT ApS (CVR 33257635) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -14,419 and a net result of DKK -592,952 compared with DKK 1,010,038 the year before. Equity in the 2021 report amounted to DKK 1,991,061. The solvency ratio was 97.8%.

Gross Profit
DKK -14,419
Profit/Loss
DKK -592,952
Equity
DKK 1,991,061
Total Assets
DKK 2,035,352

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2021--14 t.-593 t.2 mio.-
2020--20 t.1 mio.2.7 mio.-
2019--22 t.-27 t.1.8 mio.-
2018--40 t.-43 t.2 mio.0
2017--18 t.585 t.2.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like JJ PHARMA CONSULT ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2021

JJ PHARMA CONSULT ApS: The 2020 annual report is outJun 15, 2021

JJ PHARMA CONSULT ApS has published its annual report for 2020. Gross profit came to DKK -20,275, and the net result was DKK 1,010,038.

About JJ PHARMA CONSULT ApS

JJ PHARMA CONSULT ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2010. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Jack Groth Jacobsen. The company is owned by Jack Groth Jacobsen. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -79,088 and a net result of DKK -1,189,064 compared with DKK 1,260,145 the year before. Equity in the 2025 report amounted to DKK 16,917,153.

Source: annual report 2025, Danish Business Authority